Palestinians
from the world America preaches the elimination of diabetes
Confirms
the Palestinian world, Dr. Adnan Megally specialist research and medical
development of therapeutic and lives since 22 years in the United States, where
elected him "Man of the Year" in 2008 for its scientific activity, he broke
through a difficult disease, a diabetes class second-class drugs managed medical
institution founded in
1999 devised a cure of this disease completely and without complications, and
will begin production of U.S. pharmacies after two years.
Dr.
Magali, who was born in 1963 in Tubas Palestinian, holds a BA from the
University of Yarmouk in Jordan, and was a lecturer in, and then in 1986 won the
Masters, then received a scholarship to study at the Universities of Salford and
Exeter into British, and received from the latter two years after his doctorate,
he chose one
of the jobs that offered him in the United States, which happened after the
nationality.
And Dr. Magali Event "Arab. Net" company "Tranzatk Pharma" founded and turned with time into something like a medical empire headed by its Board of Directors, said she specialized conducting research and testing to find a medical systems and therapeutic drugs designed to conquer chronic diseases.Disease on a date two years later with a full recovery
It is expected Dr Magali put panacea completely Alzheimer's, is known as a cause of memory loss, a grain return to Vakadiha, after 3 years in pharmacies, as well as the expected conquer diabetes completely from the end of the year 2014 through his medication for diabetes which will come in pharmacies America in that year , "but that the drug may be delayed a year or two to reach pharmacies Arab."
He explains further recalled that the available processors now for diabetes "unable to command and control its level in a large proportion of patients, because drugs protein derived from gene GLP1 and given to patients injectables, effectively working well in patients with type II diabetes, but causing complications and associated side effects such as nausea and disorders digestive, heart disease and cancer. "
For this reason, managed his company to discover and develop new drug for diabetes which TTP054 which is addressed كحبة through the mouth, which is derived from the protein GLP1 known, but grain stimulant to Jane GLP1R in the gut and into the body, in the process aimed at controlling blood sugar and treat obesity and cholesterol without complications and side effects sufficient to treat diabetes type II class, a new biological method to control the disease recently submitted his company to the Food and Drug Administration, a body "FDA" known as the FDA acronym for its name in English.
Have shown the drug TTP054 in a previous study lasted 28 days in patients with type II diabetes is controlled with medication "Metformin" known, a pattern of safety to the extent that excellent revealed decline statistically significant levels "glucose" before and after eating for the duration of the study showed also the effectiveness of the drug and not caused by complications, such as nausea and others, as well as the apparent decrease of lipids in their blood. Currently, the drug is subject to medical studies on more than 150 patients in more than 10 medical centers in the United States of America, where the preliminary results will be available soon.
Complete treatment without coma or complications
The previously discovered Company Dr. Magali new drug treated diabetes class second-class, and working style biologist to activate and stimulate gene named GK, so is absorbed sugar in excess of the body's need through the liver and burned mechanism biological within the liver, and is controlled blood sugar and return to the normal level in isolation from the role of the pancreas.
The medication does not work if the blood sugar level by putting natural, what is useful in non-patient's exposure to cases coma because of falling sugar level as is the case when you receive a patient an overdose of insulin injections, "a scientific breakthrough important will end the suffering of millions of people infected in the world , "according to what he said about the drug, which bears the name of currently TTP399.
He explained Dr. Magali details an agreement signed by his company with laboratories "Forest" of America in 2010 and included medication TTP399 to treat diabetes, said it would pay under his company an amount of up to one billion and 105 million dollars as payments Introduction key for the development and marketing of vehicles stimulant (Gluckukinas) that promote liver , and will also pay up to 21% of annual income exclusively for sales of this medicine for more than thirty years.
No agreement includes property rights in the Middle East and North Africa, "because I wanted to keep the two regions as a matter of responsibility to provide treatment as soon as possible for our nation Arab affordable, and coincide with the supplied in global markets, as well as investment in the pharmaceutical capital of Arab or partially with American companies The European ", according to the source.
It is expected Dr Magali that this breakthrough medical lead to the end of radical suffering of more than 300 million people with diabetes and obesity in the world, "because existing drugs now is to treat the symptoms of the disease and control the level of sugar in the blood, while serving treatment Apetkrnah the causes of diabetes and treatment the disease from its roots completely. "Treatment centers give Arab food security
It is chronic diseases that works Dr. Magali on conquer is Alzheimer's reached his company in 2006 to cure him and certainly discovering a new drug named TTP488 now, handles Alzheimer's known that the state of imbalance and decline continuously functions nervous, notably the lack of balance gene in the body called Rege, what leads to a reduction or even a lack of cognitive abilities, which makes the disease the sixth cause of death in the world, and living in the United States alone nearly 5 million, while increasing to 35 million people in the world who could see a high number in 2050 to 115 million.
However, there was no treatment slows the progression of the disease to the patient, and available drugs do not work only on improving the symptoms are temporary and only partial, to be brought "Tranzatk Pharma" a major breakthrough in the treatment of disease work on the findings with him later to develop a new drug called TTP488 which is in the form of pills caliber 5 mg daily and is working to restore the biological balance of a way to defeat the disease gene.
Mentions Dr. Magali that once advertised drug discovery wizard for Alzheimer approached major international manufacturers of drugs, a "Pfizer" famous, providing offers for the company "Tranzatk Pharma", a contract was signed / agreement in 2006 about $ 178 million in advance, got under which the rights Full of manufacturing and marketing, followed by successive deliveries, in addition to part of the profits could reach more than two billion dollars when put the drug on the market, as well as 21% of their annual income exclusively for sales of the drug for more than 30 years.
The current studies have shown that TTP488 medical evidence refers to the effectiveness of a drug for Alzheimer's disease 18 months after treatment. And able "Tranzatk Pharma" this year to recover their rights for this drug to complete the development and later marketed after 3 years.
He called Dr. Magali Arab governments to work hard to develop laws and regulations that protect scientists and scientific research and the provision of specialized cadres to conduct the studies pharmaceutical, and the establishment of treatment centers in the Arab states themselves fit in with new drugs, especially that the costs of the center one of not more than $ 4 million, adding that the centers of this kind gives Arab security pharmacological
And Dr. Magali Event "Arab. Net" company "Tranzatk Pharma" founded and turned with time into something like a medical empire headed by its Board of Directors, said she specialized conducting research and testing to find a medical systems and therapeutic drugs designed to conquer chronic diseases.Disease on a date two years later with a full recovery
It is expected Dr Magali put panacea completely Alzheimer's, is known as a cause of memory loss, a grain return to Vakadiha, after 3 years in pharmacies, as well as the expected conquer diabetes completely from the end of the year 2014 through his medication for diabetes which will come in pharmacies America in that year , "but that the drug may be delayed a year or two to reach pharmacies Arab."
He explains further recalled that the available processors now for diabetes "unable to command and control its level in a large proportion of patients, because drugs protein derived from gene GLP1 and given to patients injectables, effectively working well in patients with type II diabetes, but causing complications and associated side effects such as nausea and disorders digestive, heart disease and cancer. "
For this reason, managed his company to discover and develop new drug for diabetes which TTP054 which is addressed كحبة through the mouth, which is derived from the protein GLP1 known, but grain stimulant to Jane GLP1R in the gut and into the body, in the process aimed at controlling blood sugar and treat obesity and cholesterol without complications and side effects sufficient to treat diabetes type II class, a new biological method to control the disease recently submitted his company to the Food and Drug Administration, a body "FDA" known as the FDA acronym for its name in English.
Have shown the drug TTP054 in a previous study lasted 28 days in patients with type II diabetes is controlled with medication "Metformin" known, a pattern of safety to the extent that excellent revealed decline statistically significant levels "glucose" before and after eating for the duration of the study showed also the effectiveness of the drug and not caused by complications, such as nausea and others, as well as the apparent decrease of lipids in their blood. Currently, the drug is subject to medical studies on more than 150 patients in more than 10 medical centers in the United States of America, where the preliminary results will be available soon.
Complete treatment without coma or complications
The previously discovered Company Dr. Magali new drug treated diabetes class second-class, and working style biologist to activate and stimulate gene named GK, so is absorbed sugar in excess of the body's need through the liver and burned mechanism biological within the liver, and is controlled blood sugar and return to the normal level in isolation from the role of the pancreas.
The medication does not work if the blood sugar level by putting natural, what is useful in non-patient's exposure to cases coma because of falling sugar level as is the case when you receive a patient an overdose of insulin injections, "a scientific breakthrough important will end the suffering of millions of people infected in the world , "according to what he said about the drug, which bears the name of currently TTP399.
He explained Dr. Magali details an agreement signed by his company with laboratories "Forest" of America in 2010 and included medication TTP399 to treat diabetes, said it would pay under his company an amount of up to one billion and 105 million dollars as payments Introduction key for the development and marketing of vehicles stimulant (Gluckukinas) that promote liver , and will also pay up to 21% of annual income exclusively for sales of this medicine for more than thirty years.
No agreement includes property rights in the Middle East and North Africa, "because I wanted to keep the two regions as a matter of responsibility to provide treatment as soon as possible for our nation Arab affordable, and coincide with the supplied in global markets, as well as investment in the pharmaceutical capital of Arab or partially with American companies The European ", according to the source.
It is expected Dr Magali that this breakthrough medical lead to the end of radical suffering of more than 300 million people with diabetes and obesity in the world, "because existing drugs now is to treat the symptoms of the disease and control the level of sugar in the blood, while serving treatment Apetkrnah the causes of diabetes and treatment the disease from its roots completely. "Treatment centers give Arab food security
It is chronic diseases that works Dr. Magali on conquer is Alzheimer's reached his company in 2006 to cure him and certainly discovering a new drug named TTP488 now, handles Alzheimer's known that the state of imbalance and decline continuously functions nervous, notably the lack of balance gene in the body called Rege, what leads to a reduction or even a lack of cognitive abilities, which makes the disease the sixth cause of death in the world, and living in the United States alone nearly 5 million, while increasing to 35 million people in the world who could see a high number in 2050 to 115 million.
However, there was no treatment slows the progression of the disease to the patient, and available drugs do not work only on improving the symptoms are temporary and only partial, to be brought "Tranzatk Pharma" a major breakthrough in the treatment of disease work on the findings with him later to develop a new drug called TTP488 which is in the form of pills caliber 5 mg daily and is working to restore the biological balance of a way to defeat the disease gene.
Mentions Dr. Magali that once advertised drug discovery wizard for Alzheimer approached major international manufacturers of drugs, a "Pfizer" famous, providing offers for the company "Tranzatk Pharma", a contract was signed / agreement in 2006 about $ 178 million in advance, got under which the rights Full of manufacturing and marketing, followed by successive deliveries, in addition to part of the profits could reach more than two billion dollars when put the drug on the market, as well as 21% of their annual income exclusively for sales of the drug for more than 30 years.
The current studies have shown that TTP488 medical evidence refers to the effectiveness of a drug for Alzheimer's disease 18 months after treatment. And able "Tranzatk Pharma" this year to recover their rights for this drug to complete the development and later marketed after 3 years.
He called Dr. Magali Arab governments to work hard to develop laws and regulations that protect scientists and scientific research and the provision of specialized cadres to conduct the studies pharmaceutical, and the establishment of treatment centers in the Arab states themselves fit in with new drugs, especially that the costs of the center one of not more than $ 4 million, adding that the centers of this kind gives Arab security pharmacological
No comments:
Post a Comment